Clinic Director
Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany
Würzburg, Bayern, Germany
Hermann Einsele is Full Professor of Internal Medicine and Director of the Department of Internal Medicine II, University Hospital Würzburg, Germany.
Following his medical training at the Universities of Tübingen, Manchester, and London, Hermann Einsele became a research fellow in the Department of Hematology, Oncology, Rheumatology, and Immunology at the University of Tübingen, Germany. Hermann Einsele was board certified in Internal Medicine in 1991 and in Haematology/Oncology in 1996. In 1999, he was promoted to Associate Professor.
From 2011-2015 and since 2022 Hermann Einsele is Vice Dean of the Faculty of Medicine, from 2015 -2021 Vice President of the University of Würzburg. Since 2018, he is chair of the SWG on immunotherapy for hematological malignancies of the EHA. Since 11/2023 he is a member of the Academia Europaea and since 7/2024 member of the National Academy of Sciences Leopoldina.
In 2003, he received the van Bekkum Award, the highest Annual European award for research in the field of stem cell transplantation. In 2011, he was elected as an Honorary Fellow of the Royal College of Pathologists (London) and in 2012 Nobel Lecturer Stem Cell Biology/ Transplantation, Nobel Forum Karolinska Institute. Since 2014, he was elected as a member of the Academy of Sciences and Literature, Mainz and as an ISI “Highly Cited Researcher” in the category Clinical Medicine since 2017. In 2022, Prof. Einsele received the Erasmus Hematology Award from the Erasmus University Medical Center, Rotterdam, Netherlands and the Bavarian Constitutional Medal. In 2023, he received the Emil von Behring Prize from the German Society for Transfusion Medicine and Immunohematology. In 2024 he received the Ken Anderson Basic and Translational Research Award from the IMS.
Hermann Einsele is expert in the field of multiple myeloma with focus on CAR T cells, bi-specific antibodies, adoptive immunotherapy and stem cell transplantation.
Disclosure information not submitted.
Thursday, September 18, 2025
09:55 - 10:20 East Coast USA Time